Skip to content
Home/Companies/HealthTech/STAT-Dx
SD

STAT-Dx

HealthTech·Spain·Exited 2018·Held 5yr

STAT-Dx is a HealthTech company, headquartered in Spain.

Entry
2013
Hold
5yr
Exit
2018
Est. EV
–

Who owns STAT-Dx?

STAT-Dx was owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage) from 2013 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

Boehringer Ingelheim Venture Fund
Investor
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund · 2010 · Evergreen

Key facts

HQSpain
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Boehringer Ingelheim Venture Fund

Other portfolio companies in the same fund.

ProTgen
Active
BiotechUnited States· 2024
Refoxy Pharmaceuticals
Active
BiotechGermany· 2024
SwitchKine
Active
BiotechSwitzerland· 2024
Synthetica Pioneering
Active
BiotechChina· 2024
Aurobac Therapeutics
Active
BiotechFrance· 2023
Glox Therapeutics
Active
BiotechUnited Kingdom· 2023

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings